HEADER OXYGEN TRANSPORT 26-JUL-12 4B3W TITLE CRYSTAL STRUCTURE OF HUMAN CYTOGLOBIN H(E7)Q MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOGLOBIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HISTOGLOBIN, HGB, STELLATE CELL ACTIVATION-ASSOCIATED COMPND 5 PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS KEYWDS OXYGEN TRANSPORT, METAL BINDING PROTEIN, HEME HEXACOORDINATION, KEYWDS 2 PROTEIN CAVITY EXPDTA X-RAY DIFFRACTION AUTHOR M.GABBA,S.ABBRUZZETTI,F.SPYRAKIS,F.FORTI,S.BRUNO,A.MOZZARELLI, AUTHOR 2 F.J.LUQUE,C.VIAPPIANI,P.COZZINI,M.NARDINI,F.GERMANI,M.BOLOGNESI, AUTHOR 3 L.MOENS,S.DEWILDE REVDAT 2 20-DEC-23 4B3W 1 REMARK LINK REVDAT 1 23-JAN-13 4B3W 0 JRNL AUTH M.GABBA,S.ABBRUZZETTI,F.SPYRAKIS,F.FORTI,S.BRUNO, JRNL AUTH 2 A.MOZZARELLI,F.J.LUQUE,C.VIAPPIANI,P.COZZINI,M.NARDINI, JRNL AUTH 3 F.GERMANI,M.BOLOGNESI,L.MOENS,S.DEWILDE JRNL TITL CO REBINDING KINETICS AND MOLECULAR DYNAMICS SIMULATIONS JRNL TITL 2 HIGHLIGHT DYNAMIC REGULATION OF INTERNAL CAVITIES IN HUMAN JRNL TITL 3 CYTOGLOBIN. JRNL REF PLOS ONE V. 8 49770 2013 JRNL REFN ESSN 1932-6203 JRNL PMID 23308092 JRNL DOI 10.1371/JOURNAL.PONE.0049770 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 8150 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 907 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 584 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2550 REMARK 3 BIN FREE R VALUE SET COUNT : 73 REMARK 3 BIN FREE R VALUE : 0.3360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2462 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.71000 REMARK 3 B22 (A**2) : -1.35000 REMARK 3 B33 (A**2) : 5.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.456 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.342 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 38.861 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.874 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2658 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3634 ; 1.020 ; 2.061 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 308 ; 4.422 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 117 ;33.315 ;23.675 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 438 ;20.116 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;21.782 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 375 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2004 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1548 ; 0.212 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2486 ; 0.427 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1110 ; 0.674 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1147 ; 1.167 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 18 A 400 REMARK 3 ORIGIN FOR THE GROUP (A): -22.1165 5.3621 -4.9523 REMARK 3 T TENSOR REMARK 3 T11: 0.1082 T22: 0.0312 REMARK 3 T33: 0.0094 T12: 0.0068 REMARK 3 T13: -0.0172 T23: -0.0060 REMARK 3 L TENSOR REMARK 3 L11: 4.4523 L22: 3.3692 REMARK 3 L33: 4.0079 L12: 0.5451 REMARK 3 L13: 0.1931 L23: 0.3329 REMARK 3 S TENSOR REMARK 3 S11: 0.0138 S12: -0.3022 S13: 0.0185 REMARK 3 S21: 0.0606 S22: -0.0273 S23: -0.0997 REMARK 3 S31: 0.0163 S32: 0.1355 S33: 0.0135 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 18 B 400 REMARK 3 ORIGIN FOR THE GROUP (A): -33.5045 -5.1884 -25.0892 REMARK 3 T TENSOR REMARK 3 T11: 0.0793 T22: 0.0377 REMARK 3 T33: 0.0370 T12: 0.0234 REMARK 3 T13: -0.0092 T23: -0.0307 REMARK 3 L TENSOR REMARK 3 L11: 6.6280 L22: 4.1891 REMARK 3 L33: 3.0115 L12: 0.2346 REMARK 3 L13: -0.5160 L23: -0.3894 REMARK 3 S TENSOR REMARK 3 S11: -0.0015 S12: 0.2994 S13: -0.2719 REMARK 3 S21: -0.0589 S22: -0.1363 S23: -0.0588 REMARK 3 S31: 0.1075 S32: -0.1090 S33: 0.1378 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. USING PROCHECK AS IMPLEMENTED IN CCP4 GIVES NO REMARK 3 RAMACHANDRAN OUTLIERS. REMARK 4 REMARK 4 4B3W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1290053511. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9092 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 57.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1UT0 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 4000, 0.2M NACL, 0.05M NA REMARK 280 -ACETATE (PH 4.1-4.6), 0.01M K-FERRICYANIDE, 1MM KCN, PH 4.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.42200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.03600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.02700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.03600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.42200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.02700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 LYS A 3 REMARK 465 VAL A 4 REMARK 465 PRO A 5 REMARK 465 GLY A 6 REMARK 465 GLU A 7 REMARK 465 MET A 8 REMARK 465 GLU A 9 REMARK 465 ILE A 10 REMARK 465 GLU A 11 REMARK 465 ARG A 12 REMARK 465 ARG A 13 REMARK 465 GLU A 14 REMARK 465 ARG A 15 REMARK 465 SER A 16 REMARK 465 GLU A 17 REMARK 465 VAL A 172 REMARK 465 GLN A 173 REMARK 465 GLN A 174 REMARK 465 VAL A 175 REMARK 465 PRO A 176 REMARK 465 ASN A 177 REMARK 465 ALA A 178 REMARK 465 THR A 179 REMARK 465 THR A 180 REMARK 465 PRO A 181 REMARK 465 PRO A 182 REMARK 465 ALA A 183 REMARK 465 THR A 184 REMARK 465 LEU A 185 REMARK 465 PRO A 186 REMARK 465 SER A 187 REMARK 465 SER A 188 REMARK 465 GLY A 189 REMARK 465 PRO A 190 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 LYS B 3 REMARK 465 VAL B 4 REMARK 465 PRO B 5 REMARK 465 GLY B 6 REMARK 465 GLU B 7 REMARK 465 MET B 8 REMARK 465 GLU B 9 REMARK 465 ILE B 10 REMARK 465 GLU B 11 REMARK 465 ARG B 12 REMARK 465 ARG B 13 REMARK 465 GLU B 14 REMARK 465 ARG B 15 REMARK 465 SER B 16 REMARK 465 GLU B 17 REMARK 465 VAL B 172 REMARK 465 GLN B 173 REMARK 465 GLN B 174 REMARK 465 VAL B 175 REMARK 465 PRO B 176 REMARK 465 ASN B 177 REMARK 465 ALA B 178 REMARK 465 THR B 179 REMARK 465 THR B 180 REMARK 465 PRO B 181 REMARK 465 PRO B 182 REMARK 465 ALA B 183 REMARK 465 THR B 184 REMARK 465 LEU B 185 REMARK 465 PRO B 186 REMARK 465 SER B 187 REMARK 465 SER B 188 REMARK 465 GLY B 189 REMARK 465 PRO B 190 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 37 66.65 -111.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 200 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 113 NE2 REMARK 620 2 HEM A 200 NA 96.0 REMARK 620 3 HEM A 200 NB 93.0 92.0 REMARK 620 4 HEM A 200 NC 82.2 178.0 87.3 REMARK 620 5 HEM A 200 ND 85.2 89.2 177.9 91.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 200 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 113 NE2 REMARK 620 2 HEM B 200 NA 90.5 REMARK 620 3 HEM B 200 NB 86.9 89.2 REMARK 620 4 HEM B 200 NC 87.7 177.9 89.7 REMARK 620 5 HEM B 200 ND 91.3 91.7 178.0 89.4 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CYN A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FC6 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CYN B 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FC6 B 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1172 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UMO RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE REMARK 900 DISCOVERED IN AMN REMARK 900 RELATED ID: 1URV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED REMARK 900 IN MAN DISPLAYS HEME HEXA-COORDINATION REMARK 900 RELATED ID: 1URY RELATED DB: PDB REMARK 900 CYTOGLOBIN CAVITIES REMARK 900 RELATED ID: 1UT0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED REMARK 900 IN MAN DISPLAYS HEME HEXA-COORDINATION REMARK 900 RELATED ID: 1UX9 RELATED DB: PDB REMARK 900 MAPPING PROTEIN MATRIX CAVITIES IN HUMAN CYTOGLOBIN THROUGH XE ATOM REMARK 900 BINDING: A CRYSTALLOGRAPHIC INVESTIGATION REMARK 900 RELATED ID: 1V5H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYTOGLOBIN (FERRIC FORM) REMARK 900 RELATED ID: 2DC3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYTOGLOBIN AT 1.68 ANGSTROMS RESOLUTION DBREF 4B3W A 1 190 UNP Q8WWM9 CYGB_HUMAN 1 190 DBREF 4B3W B 1 190 UNP Q8WWM9 CYGB_HUMAN 1 190 SEQADV 4B3W SER A 38 UNP Q8WWM9 CYS 38 ENGINEERED MUTATION SEQADV 4B3W GLN A 81 UNP Q8WWM9 HIS 81 ENGINEERED MUTATION SEQADV 4B3W SER A 83 UNP Q8WWM9 CYS 83 ENGINEERED MUTATION SEQADV 4B3W SER B 38 UNP Q8WWM9 CYS 38 ENGINEERED MUTATION SEQADV 4B3W GLN B 81 UNP Q8WWM9 HIS 81 ENGINEERED MUTATION SEQADV 4B3W SER B 83 UNP Q8WWM9 CYS 83 ENGINEERED MUTATION SEQRES 1 A 190 MET GLU LYS VAL PRO GLY GLU MET GLU ILE GLU ARG ARG SEQRES 2 A 190 GLU ARG SER GLU GLU LEU SER GLU ALA GLU ARG LYS ALA SEQRES 3 A 190 VAL GLN ALA MET TRP ALA ARG LEU TYR ALA ASN SER GLU SEQRES 4 A 190 ASP VAL GLY VAL ALA ILE LEU VAL ARG PHE PHE VAL ASN SEQRES 5 A 190 PHE PRO SER ALA LYS GLN TYR PHE SER GLN PHE LYS HIS SEQRES 6 A 190 MET GLU ASP PRO LEU GLU MET GLU ARG SER PRO GLN LEU SEQRES 7 A 190 ARG LYS GLN ALA SER ARG VAL MET GLY ALA LEU ASN THR SEQRES 8 A 190 VAL VAL GLU ASN LEU HIS ASP PRO ASP LYS VAL SER SER SEQRES 9 A 190 VAL LEU ALA LEU VAL GLY LYS ALA HIS ALA LEU LYS HIS SEQRES 10 A 190 LYS VAL GLU PRO VAL TYR PHE LYS ILE LEU SER GLY VAL SEQRES 11 A 190 ILE LEU GLU VAL VAL ALA GLU GLU PHE ALA SER ASP PHE SEQRES 12 A 190 PRO PRO GLU THR GLN ARG ALA TRP ALA LYS LEU ARG GLY SEQRES 13 A 190 LEU ILE TYR SER HIS VAL THR ALA ALA TYR LYS GLU VAL SEQRES 14 A 190 GLY TRP VAL GLN GLN VAL PRO ASN ALA THR THR PRO PRO SEQRES 15 A 190 ALA THR LEU PRO SER SER GLY PRO SEQRES 1 B 190 MET GLU LYS VAL PRO GLY GLU MET GLU ILE GLU ARG ARG SEQRES 2 B 190 GLU ARG SER GLU GLU LEU SER GLU ALA GLU ARG LYS ALA SEQRES 3 B 190 VAL GLN ALA MET TRP ALA ARG LEU TYR ALA ASN SER GLU SEQRES 4 B 190 ASP VAL GLY VAL ALA ILE LEU VAL ARG PHE PHE VAL ASN SEQRES 5 B 190 PHE PRO SER ALA LYS GLN TYR PHE SER GLN PHE LYS HIS SEQRES 6 B 190 MET GLU ASP PRO LEU GLU MET GLU ARG SER PRO GLN LEU SEQRES 7 B 190 ARG LYS GLN ALA SER ARG VAL MET GLY ALA LEU ASN THR SEQRES 8 B 190 VAL VAL GLU ASN LEU HIS ASP PRO ASP LYS VAL SER SER SEQRES 9 B 190 VAL LEU ALA LEU VAL GLY LYS ALA HIS ALA LEU LYS HIS SEQRES 10 B 190 LYS VAL GLU PRO VAL TYR PHE LYS ILE LEU SER GLY VAL SEQRES 11 B 190 ILE LEU GLU VAL VAL ALA GLU GLU PHE ALA SER ASP PHE SEQRES 12 B 190 PRO PRO GLU THR GLN ARG ALA TRP ALA LYS LEU ARG GLY SEQRES 13 B 190 LEU ILE TYR SER HIS VAL THR ALA ALA TYR LYS GLU VAL SEQRES 14 B 190 GLY TRP VAL GLN GLN VAL PRO ASN ALA THR THR PRO PRO SEQRES 15 B 190 ALA THR LEU PRO SER SER GLY PRO HET HEM A 200 43 HET CYN A 300 2 HET FC6 A 400 13 HET HEM B 200 43 HET CYN B 300 2 HET FC6 B 400 13 HET ACT B1172 4 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM CYN CYANIDE ION HETNAM FC6 HEXACYANOFERRATE(3-) HETNAM ACT ACETATE ION HETSYN HEM HEME HETSYN FC6 FERRI(III)HEXACYANIDE FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 CYN 2(C N 1-) FORMUL 5 FC6 2(C6 FE N6) FORMUL 9 ACT C2 H3 O2 1- FORMUL 10 HOH *22(H2 O) HELIX 1 1 SER A 20 TYR A 35 1 16 HELIX 2 2 ASN A 37 PHE A 53 1 17 HELIX 3 3 PRO A 54 PHE A 60 5 7 HELIX 4 4 ASP A 68 SER A 75 1 8 HELIX 5 5 SER A 75 ASN A 95 1 21 HELIX 6 6 ASP A 98 LYS A 116 1 19 HELIX 7 7 VAL A 122 PHE A 139 1 18 HELIX 8 8 ALA A 140 PHE A 143 5 4 HELIX 9 9 PRO A 144 GLY A 170 1 27 HELIX 10 10 SER B 20 TYR B 35 1 16 HELIX 11 11 ASN B 37 PHE B 53 1 17 HELIX 12 12 PHE B 53 TYR B 59 1 7 HELIX 13 13 ASP B 68 SER B 75 1 8 HELIX 14 14 SER B 75 GLU B 94 1 20 HELIX 15 15 ASP B 98 LYS B 116 1 19 HELIX 16 16 VAL B 122 PHE B 139 1 18 HELIX 17 17 ALA B 140 PHE B 143 5 4 HELIX 18 18 PRO B 144 GLY B 170 1 27 LINK NE2 HIS A 113 FE HEM A 200 1555 1555 2.07 LINK NE2 HIS B 113 FE HEM B 200 1555 1555 2.03 SITE 1 AC1 14 PHE A 49 TYR A 59 PHE A 60 GLN A 81 SITE 2 AC1 14 ARG A 84 LEU A 89 HIS A 113 HIS A 117 SITE 3 AC1 14 VAL A 119 TYR A 123 PHE A 124 LEU A 127 SITE 4 AC1 14 CYN A 300 HOH A2011 SITE 1 AC2 3 GLN A 81 VAL A 85 HEM A 200 SITE 1 AC3 6 LYS A 125 ARG A 155 GLY A 156 TYR A 159 SITE 2 AC3 6 PRO B 54 SER B 55 SITE 1 AC4 16 GLU A 137 GLU A 138 ALA A 140 SER A 141 SITE 2 AC4 16 TYR B 59 PHE B 60 GLN B 62 GLN B 81 SITE 3 AC4 16 ARG B 84 ALA B 88 HIS B 113 HIS B 117 SITE 4 AC4 16 VAL B 119 TYR B 123 PHE B 124 CYN B 300 SITE 1 AC5 3 GLN B 81 VAL B 85 HEM B 200 SITE 1 AC6 7 PHE A 53 PRO A 54 SER A 55 LYS B 125 SITE 2 AC6 7 ARG B 155 GLY B 156 TYR B 159 SITE 1 AC7 1 GLN B 77 CRYST1 48.844 70.054 102.072 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020473 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014275 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009797 0.00000